Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response
<p>Abstract</p> <p>Background</p> <p>This study was performed to determine if a chemotherapy-induced apoptosis assay (MiCK) could predict the best therapy for patients with ovarian cancer.</p> <p>Methods</p> <p>A prospective, multi-institutional...
Main Authors: | Salom Emery, Penalver Manuel, Homesley Howard, Burrell Matthew, Garrett Audrey, Presant Cary A, Rutledge James, Chernick Michael, Hallquist Allan, Perree Mathieu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/10/1/162 |
Similar Items
-
Application of a drug-induced apoptosis assay to identify treatment strategies in recurrent or metastatic breast cancer.
by: Linda Bosserman, et al.
Published: (2015-01-01) -
Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer
by: Sari Nakao, et al.
Published: (2020-05-01) -
Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure
by: Xiaoying Chen, et al.
Published: (2018-09-01) -
Pretreatment lymphocyte-to-monocyte ratio as a predictor of survival among patients with ovarian cancer: a meta-analysis
by: Gao XP, et al.
Published: (2019-02-01) -
Pretreatment with melatonin improves ovarian tissue cryopreservation for transplantation
by: Marcos Eiji Shiroma, et al.
Published: (2021-02-01)